Filing Details

Accession Number:
0001754526-20-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-15 16:54:23
Reporting Period:
2020-01-13
Accepted Time:
2020-01-15 16:54:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739426 Osmotica Pharmaceuticals Plc OSMT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754526 Foundation Harsaul Edificio Afra
Avenida Samuel Lewis Y Calle 54
Panama R1
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-01-13 1,250,000 $5.00 22,485,297 No 4 P Indirect By Self as indirect owner of Altchem Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Self as indirect owner of Altchem Limited
Footnotes
  1. The acquisition of Ordinary Shares reported on this Form 4 (the "Acquired Shares") was made pursuant to an underwritten public offering of Ordinary Shares by Osmotica Pharmaceuticals plc (the "Issuer"). In connection with such offering, the underwriters reimbursed the Issuer for any discounts and commissions payable by the Issuer with respect to the Acquired Shares (the "Discount"). The Issuer in turn paid a fee equal to the amount of the Discount to Altchem Limited totaling $406,250 (the "Fee"), or $0.325 per share. The $5.00 per share price does not reflect payment of the Fee to Altchem Limited.
  2. Represents shares of the Issuer held by Altchem Limited. Harsaul Foundation is the indirect owner of Altchem Limited. As a result, Harsaul Foundation may be deemed to share voting and investment power with respect to the shares held by Altchem Limited.